MediWound Ltd.

NASDAQ:MDWD

Biotechnology

Healthcare
$13.68 -0.60%

-$0.09 today

Market cap
$176.61M
Beta
0.15
P/E (TTM)
-7.0
EPS (TTM)
-$2.03
52W Low $13.54High $21.26

Volume 0.16M

Average 0.09M

Income Statement

Follow revenue through to earnings.

Revenue

$16.96M

FY 2025 · Annual

-16.1% YoY

Operating Income

-$25.28M

FY 2025 · Annual

Net Income

-$23.88M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.76M26.5M18.69M20.22M16.96M
Cost of Revenue14.99M13.33M15.11M17.59M13.71M
Gross Profit8.77M13.17M3.58M2.63M3.25M
Gross Margin36.9%49.7%19.1%13.0%19.2%
Research & Development10.26M10.18M7.47M8.88M14.32M
Selling, General & Admin9.45M10.37M11.38M12.91M13.93M
Operating Expenses19.99M20.83M19.08M22.02M28.53M
Depreciation & Amortization1.24M1.27M1.3M1.48M1.86M
EBITDA(11.38M)(18.25M)(4.8M)(27.93M)(21.47M)
EBITDA Margin-47.9%-68.9%-25.7%-138.1%-126.6%
Operating Income(11.22M)(7.66M)(15.5M)(19.38M)(25.28M)
Operating Margin-47.2%-28.9%-83.0%-95.8%-149.1%
Interest Income11K270K2.34M2.05M1.86M
Interest Expense167K162K335K561K663K
Other Income / Expenses(2.3M)(11.86M)8.97M(10.78M)1.57M
Income Before Tax(13.52M)(19.52M)(6.53M)(30.16M)(23.71M)
Pre-Tax Margin-56.9%-73.7%-35.0%-149.2%-139.8%
Income Tax Expense27K78K185K61K169K
Net Income(13.55M)(19.6M)(6.72M)(30.22M)(23.88M)
Net Margin-57.0%-74.0%-35.9%-149.5%-140.8%
EPS (Basic)(3.48)(3.93)(0.75)(3.03)(2.10)
EPS (Diluted)(3.48)(3.93)(0.75)(3.03)(2.10)
Weighted Avg Shares3.89M4.99M9.01M9.96M11.38M
Weighted Avg Shares (Diluted)3.89M4.99M9.01M9.96M11.38M

MDWD Earnings Waterfall · TTM

NASDAQ:MDWD · Revenue to Net Income

Key Ratios

EPS$-2.26
Gross Margin19.2%
Net Margin-216.8%
P/E Ratio-12.1
P/S Ratio85.2

Analysis

$14.5M of revenue converted into -$26.1M of net income for the selected period. Gross margin is 19.2% and net margin is -216.8%, showing how much revenue survives after costs and taxes. EPS is $-2.26, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
6-K6-K filingNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026

How much revenue does MDWD generate?

MediWound Ltd. (MDWD) reported $16.96M of revenue in fiscal 2025.

Is MDWD profitable?

MediWound Ltd. (MDWD) reported -$23.88M of net income, with a net margin of -140.8%.